On September 19, 2023 Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, reported that Vincerx’s CEO Ahmed Hamdy, M.D. and the Management Team will participate in a panel presentation and one-on-one investor meetings at the Cantor Fitzgerald Global Healthcare Conference 2023, to be held in New York, NY, September 26-28, 2023 (Press release, Vincerx Pharma, SEP 19, 2023, View Source [SID1234635253]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Presentation Details
Panel Date/Time:
Wednesday, September 27, 2023 at 9:10 a.m. ET
Speaker: CEO Ahmed Hamdy, M.D.
Investor Access: View Source
1X1 meetings The Vincerx Management Team will be available for 1X1 meetings during the conference. Those interested in requesting a meeting should contact their Cantor Fitzgerald sales representative.
A copy of the Company corporate presentation is available here and a recording of the panel presentation can be accessed through the "Investor Calendar" section of the Vincerx website where it will be archived for 90 days.